DB
BOLT icon

Danske Bank’s Bolt Biotherapeutics BOLT Stock Holding History

Danske Bank’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$6 – 1501
2025
Q2 		$6 Buy
+1
New +$7 ﹤0.01% 1472

Other funds holding BOLT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Danske Bank's BOLT Position: Q3 2025 in Review

Danske Bank sold out of Bolt Biotherapeutics (BOLT) in Q3 2025, closing a stake of 1 share — an estimated $6 sold.

Danske Bank first reported a position in BOLT in Q2 2025 and held it in 1 quarter. The position peaked at $6 in Q2 2025. 24 funds tracked by Wall St. Rank hold BOLT as of Q3 2025.

  • Danske Bank reported no remaining Bolt Biotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Danske Bank sold 1 Bolt Biotherapeutics share in Q3 2025, an estimated $6.
  • Danske Bank first reported a position in Bolt Biotherapeutics in Q2 2025 and held it in 1 quarter.
  • Danske Bank's Bolt Biotherapeutics position peaked at $6 in Q2 2025.
  • 24 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q3 2025.

Based on Danske Bank's 13F filing for Q3 2025, filed 13 Nov 2025.